nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—PTGS2—autistic disorder	0.739	1	CbGaD
Pomalidomide—CRBN—forebrain—autistic disorder	0.0045	0.117	CbGeAlD
Pomalidomide—CRBN—telencephalon—autistic disorder	0.00414	0.107	CbGeAlD
Pomalidomide—Lenalidomide—PTGS2—autistic disorder	0.0033	0.625	CrCbGaD
Pomalidomide—CRBN—digestive system—autistic disorder	0.00316	0.0821	CbGeAlD
Pomalidomide—CRBN—head—autistic disorder	0.00258	0.0669	CbGeAlD
Pomalidomide—CRBN—nervous system—autistic disorder	0.00244	0.0635	CbGeAlD
Pomalidomide—CRBN—central nervous system—autistic disorder	0.00235	0.0611	CbGeAlD
Pomalidomide—CRBN—cerebellum—autistic disorder	0.0023	0.0597	CbGeAlD
Pomalidomide—Thalidomide—PTGS2—autistic disorder	0.00198	0.375	CrCbGaD
Pomalidomide—PTGS2—mouth—autistic disorder	0.00194	0.0505	CbGeAlD
Pomalidomide—CRBN—brain—autistic disorder	0.00187	0.0485	CbGeAlD
Pomalidomide—PTGS2—forebrain—autistic disorder	0.00123	0.0318	CbGeAlD
Pomalidomide—PTGS2—telencephalon—autistic disorder	0.00113	0.0293	CbGeAlD
Pomalidomide—CYP1A2—digestive system—autistic disorder	0.00104	0.027	CbGeAlD
Pomalidomide—PTGS2—digestive system—autistic disorder	0.00086	0.0223	CbGeAlD
Pomalidomide—ABCB1—forebrain—autistic disorder	0.000758	0.0197	CbGeAlD
Pomalidomide—CYP3A4—digestive system—autistic disorder	0.000752	0.0195	CbGeAlD
Pomalidomide—PTGS2—head—autistic disorder	0.000702	0.0182	CbGeAlD
Pomalidomide—ABCB1—telencephalon—autistic disorder	0.000697	0.0181	CbGeAlD
Pomalidomide—PTGS2—nervous system—autistic disorder	0.000665	0.0173	CbGeAlD
Pomalidomide—PTGS2—central nervous system—autistic disorder	0.00064	0.0166	CbGeAlD
Pomalidomide—PTGS2—cerebellum—autistic disorder	0.000626	0.0163	CbGeAlD
Pomalidomide—CYP3A4—nervous system—autistic disorder	0.000581	0.0151	CbGeAlD
Pomalidomide—CYP3A4—central nervous system—autistic disorder	0.00056	0.0145	CbGeAlD
Pomalidomide—ABCB1—digestive system—autistic disorder	0.000532	0.0138	CbGeAlD
Pomalidomide—PTGS2—brain—autistic disorder	0.000508	0.0132	CbGeAlD
Pomalidomide—ABCB1—head—autistic disorder	0.000434	0.0113	CbGeAlD
Pomalidomide—ABCB1—nervous system—autistic disorder	0.000411	0.0107	CbGeAlD
Pomalidomide—ABCB1—central nervous system—autistic disorder	0.000396	0.0103	CbGeAlD
Pomalidomide—ABCB1—cerebellum—autistic disorder	0.000387	0.0101	CbGeAlD
Pomalidomide—ABCB1—brain—autistic disorder	0.000314	0.00817	CbGeAlD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—autistic disorder	0.000116	0.000535	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL6—autistic disorder	0.000115	0.000533	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DHCR7—autistic disorder	0.000115	0.000529	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—CYP19A1—autistic disorder	0.000114	0.000528	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—INPP1—autistic disorder	0.000114	0.000526	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ACADSB—autistic disorder	0.000114	0.000526	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—GABRB3—autistic disorder	0.000114	0.000526	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—GABRA1—autistic disorder	0.000114	0.000526	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—ITGB3—autistic disorder	0.000113	0.000523	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—MAPK1—autistic disorder	0.000113	0.000522	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—CYP19A1—autistic disorder	0.000113	0.000521	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—autistic disorder	0.000112	0.000517	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—autistic disorder	0.000112	0.000515	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—EXT1—autistic disorder	0.000109	0.000501	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC6A8—autistic disorder	0.000109	0.000501	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—autistic disorder	0.000107	0.000496	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—IL6—autistic disorder	0.000107	0.000493	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—COMT—autistic disorder	0.000106	0.000491	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTP1—autistic disorder	0.000106	0.000488	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—MAOA—autistic disorder	0.000106	0.000487	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—COMT—autistic disorder	0.000105	0.000484	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—GSTP1—autistic disorder	0.000104	0.000482	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SLC25A12—autistic disorder	0.000104	0.000479	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DAO—autistic disorder	0.000104	0.000478	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	0.000102	0.000471	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—BTD—autistic disorder	0.000102	0.000469	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—autistic disorder	0.000101	0.000467	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—GABRB2—autistic disorder	0.000101	0.000466	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—GABRA2—autistic disorder	0.000101	0.000466	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SLC19A1—autistic disorder	0.000101	0.000466	CbGpPWpGaD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	9.99e-05	0.000461	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—UPB1—autistic disorder	9.93e-05	0.000458	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—LEP—autistic disorder	9.83e-05	0.000454	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—HRAS—autistic disorder	9.79e-05	0.000452	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTM1—autistic disorder	9.73e-05	0.000449	CbGpPWpGaD
Pomalidomide—CYP1A2—Metapathway biotransformation—GSTM1—autistic disorder	9.59e-05	0.000443	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MET—autistic disorder	9.43e-05	0.000435	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	9.38e-05	0.000433	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—MAPK1—autistic disorder	9.29e-05	0.000429	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTM5—autistic disorder	9.24e-05	0.000426	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ASMT—autistic disorder	9.24e-05	0.000426	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—autistic disorder	9.23e-05	0.000426	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	9.21e-05	0.000425	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ACADSB—autistic disorder	9.1e-05	0.00042	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—INPP1—autistic disorder	9.1e-05	0.00042	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—autistic disorder	9.02e-05	0.000416	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC1A3—autistic disorder	9.01e-05	0.000416	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—AQP4—autistic disorder	9.01e-05	0.000416	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—autistic disorder	8.96e-05	0.000414	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	8.83e-05	0.000407	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	8.71e-05	0.000402	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC25A12—autistic disorder	8.68e-05	0.000401	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—STX1A—autistic disorder	8.65e-05	0.000399	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TDO2—autistic disorder	8.64e-05	0.000399	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC19A1—autistic disorder	8.45e-05	0.00039	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TCN2—autistic disorder	8.36e-05	0.000386	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—autistic disorder	8.32e-05	0.000384	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—autistic disorder	8.22e-05	0.00038	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—COMT—autistic disorder	8.21e-05	0.000379	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTP1—autistic disorder	8.17e-05	0.000377	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—MAOA—autistic disorder	8.15e-05	0.000376	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DHCR7—autistic disorder	8.12e-05	0.000375	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—BTD—autistic disorder	8.11e-05	0.000374	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	8.09e-05	0.000374	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—WNT2—autistic disorder	8.09e-05	0.000374	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	8.06e-05	0.000372	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—CP—autistic disorder	8.03e-05	0.000371	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	7.77e-05	0.000359	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	7.76e-05	0.000358	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—RORA—autistic disorder	7.74e-05	0.000357	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—EXT1—autistic disorder	7.7e-05	0.000355	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC6A8—autistic disorder	7.7e-05	0.000355	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—autistic disorder	7.62e-05	0.000352	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADSL—autistic disorder	7.53e-05	0.000347	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTM1—autistic disorder	7.51e-05	0.000346	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	7.4e-05	0.000342	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—XDH—autistic disorder	7.38e-05	0.000341	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DAO—autistic disorder	7.35e-05	0.000339	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—STX1A—autistic disorder	7.25e-05	0.000334	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NPAS2—autistic disorder	7.25e-05	0.000334	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—autistic disorder	7.14e-05	0.000329	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—UPB1—autistic disorder	7.04e-05	0.000325	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ACADSB—autistic disorder	7.02e-05	0.000324	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—INPP1—autistic disorder	7.02e-05	0.000324	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TCN2—autistic disorder	7e-05	0.000323	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TDO2—autistic disorder	6.9e-05	0.000318	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—POMC—autistic disorder	6.87e-05	0.000317	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—TF—autistic disorder	6.83e-05	0.000315	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RPL10—autistic disorder	6.68e-05	0.000308	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADA—autistic disorder	6.68e-05	0.000308	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	6.65e-05	0.000307	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	6.6e-05	0.000305	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTM5—autistic disorder	6.55e-05	0.000302	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ASMT—autistic disorder	6.55e-05	0.000302	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DHCR7—autistic disorder	6.48e-05	0.000299	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	6.32e-05	0.000292	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	6.32e-05	0.000292	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—autistic disorder	6.32e-05	0.000292	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—BTD—autistic disorder	6.26e-05	0.000289	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC25A12—autistic disorder	6.16e-05	0.000284	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—EXT1—autistic disorder	6.15e-05	0.000284	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC6A8—autistic disorder	6.15e-05	0.000284	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—RORA—autistic disorder	6.09e-05	0.000281	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC19A1—autistic disorder	5.99e-05	0.000276	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DAO—autistic disorder	5.86e-05	0.000271	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MAOB—autistic disorder	5.71e-05	0.000263	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—UPB1—autistic disorder	5.62e-05	0.000259	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	5.51e-05	0.000254	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	5.43e-05	0.000251	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADSL—autistic disorder	5.34e-05	0.000246	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TDO2—autistic disorder	5.32e-05	0.000246	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—POMC—autistic disorder	5.31e-05	0.000245	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TPH2—autistic disorder	5.3e-05	0.000245	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—DHFR—autistic disorder	5.27e-05	0.000243	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—XDH—autistic disorder	5.23e-05	0.000242	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ASMT—autistic disorder	5.23e-05	0.000241	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTM5—autistic disorder	5.23e-05	0.000241	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DPYD—autistic disorder	5.22e-05	0.000241	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—STX1A—autistic disorder	5.14e-05	0.000237	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NPAS2—autistic disorder	5.14e-05	0.000237	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DHCR7—autistic disorder	5e-05	0.000231	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TCN2—autistic disorder	4.96e-05	0.000229	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC25A12—autistic disorder	4.91e-05	0.000227	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	4.9e-05	0.000226	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CACNA1C—autistic disorder	4.85e-05	0.000224	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC19A1—autistic disorder	4.78e-05	0.000221	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MAPK1—autistic disorder	4.78e-05	0.00022	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—EXT1—autistic disorder	4.74e-05	0.000219	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC6A8—autistic disorder	4.74e-05	0.000219	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CALCA—autistic disorder	4.74e-05	0.000219	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADA—autistic disorder	4.73e-05	0.000218	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—AVP—autistic disorder	4.73e-05	0.000218	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	4.66e-05	0.000215	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DAO—autistic disorder	4.53e-05	0.000209	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	4.48e-05	0.000207	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DHFR—autistic disorder	4.41e-05	0.000204	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	4.39e-05	0.000203	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—UPB1—autistic disorder	4.34e-05	0.0002	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—RORA—autistic disorder	4.32e-05	0.000199	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADSL—autistic disorder	4.26e-05	0.000197	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PRL—autistic disorder	4.19e-05	0.000193	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—XDH—autistic disorder	4.18e-05	0.000193	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NPAS2—autistic disorder	4.1e-05	0.000189	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—STX1A—autistic disorder	4.1e-05	0.000189	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MAOB—autistic disorder	4.04e-05	0.000187	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ASMT—autistic disorder	4.03e-05	0.000186	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM5—autistic disorder	4.03e-05	0.000186	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TCN2—autistic disorder	3.96e-05	0.000183	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—HRAS—autistic disorder	3.83e-05	0.000177	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC25A12—autistic disorder	3.79e-05	0.000175	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADA—autistic disorder	3.78e-05	0.000174	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TPH2—autistic disorder	3.76e-05	0.000174	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	3.73e-05	0.000172	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DPYD—autistic disorder	3.7e-05	0.000171	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC19A1—autistic disorder	3.69e-05	0.00017	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—autistic disorder	3.67e-05	0.000169	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	3.58e-05	0.000165	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP19A1—autistic disorder	3.46e-05	0.00016	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—RORA—autistic disorder	3.45e-05	0.000159	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CACNA1C—autistic disorder	3.44e-05	0.000159	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADSL—autistic disorder	3.29e-05	0.000152	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	3.24e-05	0.00015	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MAOB—autistic disorder	3.23e-05	0.000149	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—XDH—autistic disorder	3.22e-05	0.000149	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—COMT—autistic disorder	3.21e-05	0.000148	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTP1—autistic disorder	3.2e-05	0.000148	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MAOA—autistic disorder	3.19e-05	0.000147	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NPAS2—autistic disorder	3.17e-05	0.000146	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—STX1A—autistic disorder	3.17e-05	0.000146	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DHFR—autistic disorder	3.13e-05	0.000144	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—autistic disorder	3.11e-05	0.000144	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—autistic disorder	3.1e-05	0.000143	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HLA-A—autistic disorder	3.09e-05	0.000143	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	3.07e-05	0.000142	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TCN2—autistic disorder	3.06e-05	0.000141	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TPH2—autistic disorder	3e-05	0.000139	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DPYD—autistic disorder	2.95e-05	0.000136	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TSC2—autistic disorder	2.95e-05	0.000136	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTM1—autistic disorder	2.94e-05	0.000136	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLA2G4A—autistic disorder	2.94e-05	0.000136	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADA—autistic disorder	2.92e-05	0.000135	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOE—autistic disorder	2.89e-05	0.000133	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GPX1—autistic disorder	2.81e-05	0.00013	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.77e-05	0.000128	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CACNA1C—autistic disorder	2.75e-05	0.000127	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS2—autistic disorder	2.69e-05	0.000124	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—RORA—autistic disorder	2.66e-05	0.000123	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.64e-05	0.000122	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APC—autistic disorder	2.61e-05	0.00012	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—autistic disorder	2.6e-05	0.00012	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EGF—autistic disorder	2.58e-05	0.000119	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DHFR—autistic disorder	2.5e-05	0.000115	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MAOB—autistic disorder	2.49e-05	0.000115	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP19A1—autistic disorder	2.45e-05	0.000113	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOE—autistic disorder	2.42e-05	0.000112	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TPH2—autistic disorder	2.32e-05	0.000107	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DPYD—autistic disorder	2.28e-05	0.000105	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—COMT—autistic disorder	2.28e-05	0.000105	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTP1—autistic disorder	2.27e-05	0.000105	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SERPINE1—autistic disorder	2.27e-05	0.000105	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MAOA—autistic disorder	2.26e-05	0.000104	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—autistic disorder	2.21e-05	0.000102	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CG—autistic disorder	2.18e-05	0.000101	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CACNA1C—autistic disorder	2.12e-05	9.78e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.11e-05	9.72e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLA2G4A—autistic disorder	2.08e-05	9.62e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTM1—autistic disorder	2.08e-05	9.62e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—POMC—autistic disorder	2.08e-05	9.59e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GPX1—autistic disorder	2e-05	9.21e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP19A1—autistic disorder	1.96e-05	9.03e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DHFR—autistic disorder	1.93e-05	8.9e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—autistic disorder	1.84e-05	8.5e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.84e-05	8.48e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—COMT—autistic disorder	1.82e-05	8.39e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTP1—autistic disorder	1.81e-05	8.35e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MAOA—autistic disorder	1.81e-05	8.33e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—autistic disorder	1.76e-05	8.13e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PTEN—autistic disorder	1.73e-05	7.96e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOE—autistic disorder	1.71e-05	7.91e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTM1—autistic disorder	1.66e-05	7.68e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLA2G4A—autistic disorder	1.66e-05	7.68e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GPX1—autistic disorder	1.59e-05	7.35e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CG—autistic disorder	1.55e-05	7.14e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP19A1—autistic disorder	1.51e-05	6.97e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—POMC—autistic disorder	1.47e-05	6.8e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—autistic disorder	1.47e-05	6.78e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PTEN—autistic disorder	1.45e-05	6.67e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—COMT—autistic disorder	1.4e-05	6.48e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MAPK1—autistic disorder	1.4e-05	6.47e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTP1—autistic disorder	1.4e-05	6.45e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MAOA—autistic disorder	1.39e-05	6.43e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOE—autistic disorder	1.37e-05	6.32e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—autistic disorder	1.36e-05	6.27e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLA2G4A—autistic disorder	1.28e-05	5.92e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM1—autistic disorder	1.28e-05	5.92e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CG—autistic disorder	1.24e-05	5.7e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPX1—autistic disorder	1.23e-05	5.67e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—POMC—autistic disorder	1.18e-05	5.43e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—autistic disorder	1.17e-05	5.42e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—autistic disorder	1.13e-05	5.24e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HRAS—autistic disorder	1.13e-05	5.2e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—autistic disorder	1.08e-05	4.98e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOE—autistic disorder	1.06e-05	4.87e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTEN—autistic disorder	1.02e-05	4.73e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CG—autistic disorder	9.53e-06	4.4e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—autistic disorder	9.38e-06	4.33e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—POMC—autistic disorder	9.07e-06	4.19e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTEN—autistic disorder	8.18e-06	3.77e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—autistic disorder	7.24e-06	3.34e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTEN—autistic disorder	6.31e-06	2.91e-05	CbGpPWpGaD
